Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Insmed Inc (NQ: INSM )

25.97 -0.41 (-1.55%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,921,912
Open 26.57
Bid (Size) 25.50 (2)
Ask (Size) 26.04 (1)
Prev. Close 26.38
Today's Range 25.31 - 26.82
52wk Range 18.09 - 32.00
Shares Outstanding 115,246,666
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
INSM Stock Earnings: Insmed Beats EPS, Misses Revenue for Q1 2024
INSM stock results show that Insmed beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga

Performance

YTD
-13.26%
-13.26%
1 Month
-7.28%
-7.28%
3 Month
-9.10%
-9.10%
6 Month
+10.89%
+10.89%
1 Year
+35.47%
+35.47%

More News

Read More
Where Insmed Stands With Analysts
Via Benzinga
INSMED INC (NASDAQ:INSM) Reveals Intriguing Technical Aspects. Here's What You Need to Know.
Via Chartmill
Why Shares of Insmed Are Soaring This Week
Via The Motley Fool
Where Insmed Stands With Analysts
Via Benzinga
Why Insmed Stock Is Soaring Today
Via The Motley Fool
Insmed: Q1 Earnings Insights
Via Benzinga
Insmed's Return On Capital Employed Insights
Via Benzinga
A Preview Of Insmed's Earnings
Via Benzinga
Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Insmed Is Making A Comeback — Why Shares Hit A Year High In Colossal Volume
Via Investor's Business Daily
Why Lung Disease Focused Stock Insmed Is Trading Higher Today?
Via Benzinga
Barclays Maintains Overweight Rating for Insmed: Here's What You Need To Know
Via Benzinga
Analyst Expectations for Insmed's Future
Via Benzinga
Analyst Ratings for Insmed
Via Benzinga
What 4 Analyst Ratings Have To Say About Insmed
Via Benzinga
Brady, Airbnb, Insmed And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2023
Via Benzinga
Analysts and Executives Converge February 2nd at the 30th Annual Emerald Groundhog Day Investment Forum
From Emerald Asset Management PA, LLC
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Why Aptevo Therapeutics Shares Are Trading Higher By More Than 100%; Here Are 28 Stocks Moving Premarket
Via Benzinga
Coupa Software, Horizon Therapeutics And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
Via Benzinga
Insmed's Return On Capital Employed Overview
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.